explore -WSS

explore

author：entertainment 2025-10-01 02:13:56 - browse：4261

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Senate panel clears PBM, hopsital reforms

explore

WSS

Apple Vision Pro: A first look at health apps on the new VR headset

Cybersecurity threat forces Lurie Children's to take systems offline

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

The Sacklers, horror, and ‘The Fall of the House of Usher’

Juul spent big to court Black leaders to promote its e

Biotech incubator Curie.Bio graduates its first startup

Wikipedia

explore

focus

Activists slam private health insurers over coverage restrictions

Congressmen charge Covid hearing ‘could have been an email’

Novavax promises a turnaround & Lilly roils the obesity market

Ambulance rides for just $100? Advisers want major billing fixes

Medicare proposal to cover medical devices draws a mixed reaction

The new shift in health care is toward less care

Alkermes shareholders re

HPV cancer vaccine study demonstrates efficacy

Duchenne breakthrough therapy leaves behind pioneering families

ARCH Venture Partners is raising $3 billion for a life sciences fund

focus

Extreme heat events are a public health emergency

Cognito secures funding to test medical device for Alzheimer's

Some dementia cases could be undiagnosed liver disease

Sanofi CEO defends move to abandon profit guidance, boost research

UCSF medical school apologizes for unethical prisoner experiments

Medicare solvency divides Republicans at the presidential debate

explore

hotspot

knowledge

Wikipedia